The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
CONCLUSIONS: SUAM-14746 inhibited breast cancer cell growth in a cytostatic manner without inducing lethality, and POP-specific inhibitors may be an effective treatment against ER+ and ER- breast cancer.
PMID: 28070831 [PubMed - as supplied by publisher]
Source: Breast Cancer - Category: Cancer & Oncology Authors: Tanaka S, Suzuki K, Sakaguchi M Tags: Breast Cancer Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Epithelial Cancer | Eye Cancers | Gastric (Stomach) Cancer | Gastroenterology | Neuroblastoma | Neurology | Retinoblastoma